$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

$zvra Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000143774918005932 Filed on March 30, 2018

Income Statement

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.610M	$3.320M	$3.570M
YoY Change	-9.06%	-33.73%	-16.78%
% of Gross Profit
Research & Development	$5.536M	$6.293M	$4.650M
YoY Change	-30.48%	46.79%	-6.78%
% of Gross Profit
Depreciation & Amortization	$90.00K	$90.00K	$80.00K
YoY Change	12.5%	125.0%	166.67%
% of Gross Profit
Operating Expenses	$8.150M	$9.612M	$8.224M
YoY Change	-24.79%	-7.59%	-11.33%
Operating Profit	-$8.150M	-$9.612M	-$8.224M
YoY Change	-24.79%	-7.59%	-11.33%
Interest Expense	$1.444M	$1.448M	$1.443M
YoY Change	-0.07%	0.49%	-2.17%
% of Operating Profit
Other Income/Expense, Net	-$2.447M	-$373.0K	$1.703M
YoY Change	-373.1%	-87.7%	-91.06%
Pretax Income	-$10.60M	-$9.985M	-$6.521M
YoY Change	6.61%	-25.67%	-166.79%
Income Tax	-$31.00K	-$4.000K	-$4.000K
% Of Pretax Income
Net Earnings	-$10.57M	-$9.981M	-$6.517M
YoY Change	6.34%	-25.59%	-166.72%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.72	-$0.68	-$0.44
Diluted Earnings Per Share	-$0.72	-$0.68	-$0.44
COMMON SHARES
Basic Shares Outstanding			14.65M
Diluted Shares Outstanding			14.65M

Balance Sheet

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$42.20M	$45.20M	$53.50M
YoY Change	-37.76%	-28.82%	-35.23%
Cash & Equivalents	$10.87M	$7.829M	$12.39M
Short-Term Investments	$31.40M	$37.40M	$41.10M
Other Short-Term Assets	$2.800M	$2.500M	$1.900M
YoY Change	75.0%	47.06%	0.0%
Inventory
Prepaid Expenses
Receivables	$2.005M	$2.503M
Other Receivables	$76.00K	$0.00	$0.00
Total Short-Term Assets	$45.90M	$50.20M	$55.36M
YoY Change	-38.28%	-23.08%	-34.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.004M	$2.086M	$2.148M
YoY Change	1.73%	43.27%	94.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.300M	$6.700M	$11.20M
YoY Change	-59.76%	-75.55%	-40.74%
Other Assets	$206.0K	$313.0K	$321.0K
YoY Change	-42.78%	-33.69%	189.19%
Total Long-Term Assets	$6.560M	$9.116M	$13.68M
YoY Change	-37.7%	-68.87%	-31.81%
TOTAL ASSETS
Total Short-Term Assets	$45.90M	$50.20M	$55.36M
Total Long-Term Assets	$6.560M	$9.116M	$13.68M
Total Assets	$52.46M	$59.31M	$69.05M
YoY Change	-38.2%	-37.26%	-34.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.177M	$6.400M	$6.300M
YoY Change	364.18%	14.29%	16.67%
Accrued Expenses	$700.0K
YoY Change	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.500M	$200.0K	$200.0K
YoY Change	1650.0%	100.0%	-90.0%
Total Short-Term Liabilities	$11.51M	$6.647M	$6.592M
YoY Change	73.28%	16.53%	-10.81%
LONG-TERM LIABILITIES
Long-Term Debt	$90.00M	$92.30M	$92.00M
YoY Change	-1.32%	1.65%	1.77%
Other Long-Term Liabilities	$794.0K	$1.427M	$1.472M
YoY Change	60.08%	173.9%	207.95%
Total Long-Term Liabilities	$794.0K	$1.427M	$1.472M
YoY Change	60.08%	173.9%	207.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.51M	$6.647M	$6.592M
Total Long-Term Liabilities	$794.0K	$1.427M	$1.472M
Total Liabilities	$110.0M	$107.4M	$108.3M
YoY Change	6.17%	2.94%	3.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$164.7M	-$154.2M	-$144.2M
YoY Change	35.76%	38.38%	47.14%
Common Stock	$107.2M	$106.1M	$104.9M
YoY Change	4.45%	4.39%	6.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$57.52M	-$48.10M	-$39.28M
YoY Change
Total Liabilities & Shareholders Equity	$52.46M	$59.31M	$69.05M
YoY Change	-38.2%	-37.26%	-34.01%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	-$10.57M	-$9.981M	-$6.517M
YoY Change	6.34%	-25.59%	-166.72%
Depreciation, Depletion And Amortization	$90.00K	$90.00K	$80.00K
YoY Change	12.5%	125.0%	166.67%
Cash From Operating Activities	-$6.940M	-$10.17M	-$6.470M
YoY Change	-25.85%	22.97%	-21.77%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$40.00K	-$40.00K
YoY Change	-100.0%	-87.88%	-73.33%
Acquisitions
YoY Change
Other Investing Activities	$10.02M	$5.690M	$6.080M
YoY Change	71.87%	44.05%	-115.08%
Cash From Investing Activities	$10.01M	$5.660M	$6.040M
YoY Change	74.39%	56.79%	-114.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-30.00K	-50.00K	-60.00K
YoY Change	-93.62%	-97.5%	-400.0%
NET CHANGE
Cash From Operating Activities	-6.940M	-10.17M	-6.470M
Cash From Investing Activities	10.01M	5.660M	6.040M
Cash From Financing Activities	-30.00K	-50.00K	-60.00K
Net Change In Cash	3.040M	-4.560M	-490.0K
YoY Change	-174.33%	-31.53%	-98.99%
FREE CASH FLOW
Cash From Operating Activities	-$6.940M	-$10.17M	-$6.470M
Capital Expenditures	$0.00	-$40.00K	-$40.00K
Free Cash Flow	-$6.940M	-$10.13M	-$6.430M
YoY Change	-25.13%	27.58%	-20.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	605000
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	107209000
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	102643000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2369000
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6600000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4562000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3276000
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2222000
CY2015	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2671000
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1561000
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1616000
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1909000
CY2017Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	390000
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4562000
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6600000
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2369000
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2222000
CY2016Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	442000
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11674011
CY2017Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	391000
CY2017Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	390000
CY2017Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	390000
CY2016Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	391000
CY2016Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	390000
CY2016Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	393000
CY2015	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2017Q4	us-gaap	Assets Assets	52456000
CY2016Q4	us-gaap	Assets Assets	84887000
CY2017Q4	us-gaap	Assets Current AssetsCurrent	46996000
CY2016Q4	us-gaap	Assets Current AssetsCurrent	74357000
CY2017Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	34608000
CY2016Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	59203000
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10869947
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5714113
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	715000
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	232000
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3788000
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2409000
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3166000
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	29023000
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	260000
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	89000
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2254000
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	42965000
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48776000
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	84000
CY2015Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	80000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	336000
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	175000
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.92
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.11
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20593000
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20472000
CY2015	kmph	Conversion Of Preferred Stock To Common Stock Upon Initial Public Offering Shares ConversionOfPreferredStockToCommonStockUponInitialPublicOfferingShares	5980564
CY2015	kmph	Conversion Of Preferred Stock To Common Stock Upon Initial Public Offering Value ConversionOfPreferredStockToCommonStockUponInitialPublicOfferingValue	28207000
CY2017Q4	kmph	Debt Issuance Costs And Discount Gross DebtIssuanceCostsAndDiscountGross	3519000
CY2017Q4	kmph	Deferred Income Tax Assets Liabilities DeferredIncomeTaxAssetsLiabilities	42965000
CY2016Q4	kmph	Deferred Income Tax Assets Liabilities DeferredIncomeTaxAssetsLiabilities	48776000
CY2015Q4	kmph	Deferred Income Tax Assets Liabilities DeferredIncomeTaxAssetsLiabilities	29023000
CY2017	kmph	Deferred Offering Costs Included In Accounts Payable And Accrued Expense DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
CY2016	kmph	Deferred Offering Costs Included In Accounts Payable And Accrued Expense DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense	85000
CY2015	kmph	Deferred Offering Costs Included In Accounts Payable And Accrued Expense DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense	428000
CY2017	kmph	Deferred Offering Costs Writeoff DeferredOfferingCostsWriteoff	60000
CY2016	kmph	Deferred Offering Costs Writeoff DeferredOfferingCostsWriteoff	445000
CY2015	kmph	Deferred Offering Costs Writeoff DeferredOfferingCostsWriteoff
CY2017Q4	kmph	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	7709000
CY2016Q4	kmph	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	4618000
CY2017	kmph	Effective Income Tax Rate Reconciliation Conversion Feature And Put Option On Convertible Notes EffectiveIncomeTaxRateReconciliationConversionFeatureAndPutOptionOnConvertibleNotes
CY2016	kmph	Effective Income Tax Rate Reconciliation Conversion Feature And Put Option On Convertible Notes EffectiveIncomeTaxRateReconciliationConversionFeatureAndPutOptionOnConvertibleNotes
CY2015	kmph	Effective Income Tax Rate Reconciliation Conversion Feature And Put Option On Convertible Notes EffectiveIncomeTaxRateReconciliationConversionFeatureAndPutOptionOnConvertibleNotes	-0.0168
CY2017	kmph	Effective Income Tax Rate Reconciliation Return To Provision And Deferred Trueup EffectiveIncomeTaxRateReconciliationReturnToProvisionAndDeferredTrueup	0.0218
CY2016	kmph	Effective Income Tax Rate Reconciliation Return To Provision And Deferred Trueup EffectiveIncomeTaxRateReconciliationReturnToProvisionAndDeferredTrueup	-0.2383
CY2015	kmph	Effective Income Tax Rate Reconciliation Return To Provision And Deferred Trueup EffectiveIncomeTaxRateReconciliationReturnToProvisionAndDeferredTrueup
CY2017	kmph	Effective Income Tax Rate Reconciliation Warrant Liabilities Increase Decrease EffectiveIncomeTaxRateReconciliationWarrantLiabilitiesIncreaseDecrease	-0.0242
CY2016	kmph	Effective Income Tax Rate Reconciliation Warrant Liabilities Increase Decrease EffectiveIncomeTaxRateReconciliationWarrantLiabilitiesIncreaseDecrease	0.6844
CY2015	kmph	Effective Income Tax Rate Reconciliation Warrant Liabilities Increase Decrease EffectiveIncomeTaxRateReconciliationWarrantLiabilitiesIncreaseDecrease	-0.1528
CY2017	kmph	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
CY2016	kmph	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises	756000
CY2017	kmph	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses	3000
CY2016	kmph	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses	281000
CY2015	kmph	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
CY2017	kmph	Increase Decrease In Deferred Tax Assets IncreaseDecreaseInDeferredTaxAssets	-21.30
CY2017	kmph	Increase In Common Stock Reserved For Issuance IncreaseInCommonStockReservedForIssuance	586297
CY2017	kmph	Reclassification Of Warrant Liability To Equity ReclassificationOfWarrantLiabilityToEquity
CY2016	kmph	Reclassification Of Warrant Liability To Equity ReclassificationOfWarrantLiabilityToEquity
CY2015	kmph	Reclassification Of Warrant Liability To Equity ReclassificationOfWarrantLiabilityToEquity	1110000
CY2017Q4	kmph	Sale Of Securities Value Available To Issue SaleOfSecuritiesValueAvailableToIssue	150000000
CY2017Q4	kmph	Sale Of Stock Value Available To Issue SaleOfStockValueAvailableToIssue	20000000
CY2015	kmph	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	4749000
CY2016	kmph	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	896000
CY2017	kmph	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	4000
CY2017	kmph	Supply Arrangement Automatic Renewal Period SupplyArrangementAutomaticRenewalPeriod	P2Y
CY2017	kmph	Supply Arrangement Expense SupplyArrangementExpense	0
CY2015	kmph	Supply Arrangement Expense SupplyArrangementExpense	0
CY2016	kmph	Supply Arrangement Expense SupplyArrangementExpense	0
CY2017	kmph	Supply Arrangement Period Of Prior Notice SupplyArrangementPeriodOfPriorNotice	P1Y
CY2017	kmph	Trade Receivables TradeReceivables	2005000
CY2016	kmph	Trade Receivables TradeReceivables	5003000
CY2015	kmph	Trade Receivables TradeReceivables
CY2017	kmph	Transfer Of Warrants To Equity Upon Exercise TransferOfWarrantsToEquityUponExercise
CY2016	kmph	Transfer Of Warrants To Equity Upon Exercise TransferOfWarrantsToEquityUponExercise	755000
CY2015	kmph	Transfer Of Warrants To Equity Upon Exercise TransferOfWarrantsToEquityUponExercise	4293000
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7875000
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6444000
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2177000
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	469000
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2005000
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5003000
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	700000
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	700000
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1118000
CY2016Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1024000
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	929000
CY2016	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	867000
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	189000
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	157000
CY2017	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	284000
CY2015	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	562000
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	657000
CY2017Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	966000
CY2016Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	867000
CY2017Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	816000
CY2016Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	836000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	866000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	242000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	11000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	151000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	231000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	231000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	115000
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	751000
CY2017Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	150000
CY2016Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	31000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10871000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16762000
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17862000
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32318000
CY2014Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10255000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11971000
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5891000
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14456000
CY2015	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	22063000
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	12618711
CY2016Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	12114618
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14657430
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14646982
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14657430
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14646982
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2381041
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14490954
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1000
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	37028000
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	44984000
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26617000
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; text-indent: 0pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk</div></div></div> <div style=" margin: 0pt; text-align: justify; text-indent: 20.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Financial instruments that potentially expose<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions, the balances of which frequently exceed insured limits.</div></div></div></div></div></div>
CY2017	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1
CY2016	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1
CY2015	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	28207000
CY2017Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	89398000
CY2016Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	91170000
CY2017Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3333000
CY2016Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	96250000
CY2017	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2016	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2015	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	3276000
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	260000
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	89000
CY2015Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	80000
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	43225000
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	48865000
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29103000
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.13
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.96
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-7.42
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.11
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.92
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0009
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0005
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1338
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.6931
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1925
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.4906
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.1463
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	-0.0122
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	-0.0315
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0103
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.1271
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0128
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0004
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.001
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0149
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0271
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.1564
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0406
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	8500000
CY2017	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y21D
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3091000
CY2016	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-32465000
CY2015	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	27276000
CY2017Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	710000
CY2017Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1312000
CY2017Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3523000
CY2017Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7216000
CY2016Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2723000
CY2016Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1299000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-22814000
CY2016Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-20763000
CY2016Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10278000
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	3091000
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-32465000
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4618000
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	37839000
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7709000
CY2017	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-104000
CY2016	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-91000
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4740000
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2017Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2017Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2016Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2016Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2016Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4740000
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12773000
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14000000
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8883000
CY2017Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2614000
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3319000
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3574000
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3266000
CY2016Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2873000
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3104000
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4287000
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3736000
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-8150000
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9940000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43429000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16531000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54638000
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10597000
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9985000
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6521000
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16326000
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13433000
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9764000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2922000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-43000
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15000
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26000
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19000
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12000
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-801000
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1118000
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1315000
CY2017	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	77000
CY2016	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	184000
CY2015	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	926000
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2018000
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1228000
CY2017	us-gaap	Interest And Other Income InterestAndOtherIncome	365000
CY2016	us-gaap	Interest And Other Income InterestAndOtherIncome	353000
CY2015	us-gaap	Interest And Other Income InterestAndOtherIncome	32000
CY2017Q4	us-gaap	Interest And Other Income InterestAndOtherIncome	97000
CY2017Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	154000
CY2017Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	13000
CY2017Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	101000
CY2016Q4	us-gaap	Interest And Other Income InterestAndOtherIncome	9000
CY2016Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	98000
CY2016Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	144000
CY2016Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	102000
CY2017	us-gaap	Interest Expense InterestExpense	5776000
CY2016	us-gaap	Interest Expense InterestExpense	5511000
CY2015	us-gaap	Interest Expense InterestExpense	2671000
CY2017Q4	us-gaap	Interest Expense InterestExpense	1444000
CY2017Q3	us-gaap	Interest Expense InterestExpense	1448000
CY2017Q2	us-gaap	Interest Expense InterestExpense	1443000
CY2017Q1	us-gaap	Interest Expense InterestExpense	1441000
CY2016Q4	us-gaap	Interest Expense InterestExpense	1445000
CY2016Q3	us-gaap	Interest Expense InterestExpense	1441000
CY2016Q2	us-gaap	Interest Expense InterestExpense	1475000
CY2016Q1	us-gaap	Interest Expense InterestExpense	1150000
CY2017	us-gaap	Interest Paid Net InterestPaidNet	5717000
CY2016	us-gaap	Interest Paid Net InterestPaidNet	3289000
CY2015	us-gaap	Interest Paid Net InterestPaidNet
CY2017Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2222000
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2222000
CY2017Q4	us-gaap	Liabilities Liabilities	109972000
CY2016Q4	us-gaap	Liabilities Liabilities	103583000
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52456000
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	84887000
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11509000
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6642000
CY2017Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	7709000
CY2016Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	4618000
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	92731000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3333000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	86250000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3334000
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3333000
CY2017Q4	us-gaap	Long Term Investments LongTermInvestments	3250000
CY2016Q4	us-gaap	Long Term Investments LongTermInvestments	8200000
CY2017Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0
CY2016Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0
CY2017Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	31358000
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	51003000
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	9275000
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	6970000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-203000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61163000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61468000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27412000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45847000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19137000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33100000
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29772000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20268000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-43386000
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-16516000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-54664000
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-10566000
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-9981000
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-6517000
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-16322000
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-9936000
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-13414000
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	9768000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-2934000
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10063000
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20951000
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31824000
CY2017Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2447000
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-373000
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1703000
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8946000
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	896000
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3032000
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19039000
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4048000
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2017	us-gaap	Operating Expenses OperatingExpenses	33366000
CY2016	us-gaap	Operating Expenses OperatingExpenses	37482000
CY2015	us-gaap	Operating Expenses OperatingExpenses	22814000
CY2017Q4	us-gaap	Operating Expenses OperatingExpenses	8150000
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	9612000
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	8224000
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	7380000
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	10836000
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	10401000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-33366000
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-37482000
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	206000
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	360000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	604000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1376000
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	137331000
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1658000
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1383000
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9612000
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8224000
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7380000
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-10836000
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-10401000
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9275000
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6970000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4077000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	688000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	461000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	449000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	499000
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	112000
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	41000
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	794000
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	496000
CY2017Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	76000
CY2016Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	58000
CY2017	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts
CY2016	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	983000
CY2015	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	2533000
CY2017	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	50000
CY2016	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	164000
CY2015	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	315000
CY2017	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	27378000
CY2016	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	89849000
CY2015	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	19002000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	181000
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	643000
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	135000
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	489000
CY2015	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1662000
CY2017Q4	us-gaap	Prepaid Insurance PrepaidInsurance	202000
CY2016Q4	us-gaap	Prepaid Insurance PrepaidInsurance	333000
CY2015	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt
CY2017	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	54971000
CY2016	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	44645000
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, Serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Reclassifications</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, Serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, Serif; font-size: 10pt;">Certain prior year amounts have been reclassified to conform with current year presentation.</div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, Serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, Serif; font-size: 10pt;">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company early adopted Accounting Standards Update ("ASU") <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> <div style="display: inline; font-style: italic;">Statement of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Restricted Cash</div> (“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18”</div>), which addresses the treatment of restricted cash and restricted cash equivalents in the statement of cash flows. The adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> reduced the Company’s net cash used in investing activities and net decrease in cash and cash equivalents on the statements of cash flows by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.1</div></div> million for the year ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2016, </div>as compared to the net cash used in investing activities and net decrease in cash and cash equivalents on the statements of cash flows if the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> early adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18.</div> This reclassification had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the balance sheets, statements of operations or statements of changes in redeemable convertible preferred stock and stockholders' deficit. The Company did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have restricted cash for the year ended <div style="display: inline; font-style: italic; font-style: normal; font-weight: inherit;"> December 31, 2015.</div></div></div></div></div></div>
CY2017	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering
CY2016	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering
CY2015	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	59892000
CY2017	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt
CY2016	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	82800000
CY2017	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4000
CY2016	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	141000
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	413000
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2933000
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2575000
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2004000
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1970000
CY2017	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt
CY2016	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1931000
CY2015	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt
CY2017	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	157000
CY2016	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	79000
CY2015	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	32000
CY2017	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2016	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	18621000
CY2015	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6293000
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13931000
CY2017Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5536000
CY2015Q4	us-gaap	Restricted Cash RestrictedCash	0
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4650000
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4114000
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7963000
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4287000
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4988000
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3234000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1100000
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1100000
CY2016	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	3
CY2017Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	646000
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-164726000
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-121340000
CY2017	us-gaap	Sales Revenue Net SalesRevenueNet
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet
CY2017Q4	us-gaap	Sales Revenue Net SalesRevenueNet
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet
CY2017	us-gaap	Severance Costs1 SeveranceCosts1
CY2016	us-gaap	Severance Costs1 SeveranceCosts1	3010000
CY2015	us-gaap	Severance Costs1 SeveranceCosts1
CY2017Q4	us-gaap	Severance Costs1 SeveranceCosts1
CY2017Q3	us-gaap	Severance Costs1 SeveranceCosts1
CY2017Q2	us-gaap	Severance Costs1 SeveranceCosts1
CY2017Q1	us-gaap	Severance Costs1 SeveranceCosts1
CY2016Q4	us-gaap	Severance Costs1 SeveranceCosts1
CY2016Q3	us-gaap	Severance Costs1 SeveranceCosts1	3010000
CY2016Q2	us-gaap	Severance Costs1 SeveranceCosts1
CY2016Q1	us-gaap	Severance Costs1 SeveranceCosts1
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	4562000
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	6600000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	2369000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1044392
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.38
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	32000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	169000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	54000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	6666
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	38920
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	919000
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	26400
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	471539
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1990260
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2853924
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.64
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.50
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	440178
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2760447
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	10.62
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.75
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	4.65
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.35
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.59
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y98D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y328D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y317D
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	29237
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y284D
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1809532
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1352768
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4100000
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	5400000
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1100000
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	13333
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	163998
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.77
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	9.25
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	10.63
CY2017	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-43000
CY2016	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-15000
CY2015	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-15000
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	9750
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	14933
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4766
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	59892000
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7000
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	71000
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	28000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-57516000
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-18696000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-48508000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-10121000
CY2017Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding
CY2015Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding
CY2016Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP")<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">On an ongoing basis, the Company evaluates its estimates, includ<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">ing those related to the useful lives of property and equipment, and assumptions used for purposes of determining stock-based compensation, income taxes, and the fair value of the derivative and warrant liability, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</div></div></div></div></div></div>
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14652898
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14597053
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7368681
CY2016	kmph	Adjustment To Additional Paid In Capital Writeoff Of Deferred Offering Costs AdjustmentToAdditionalPaidInCapitalWriteoffOfDeferredOfferingCosts	445000
CY2015	kmph	Adjustments To Additional Paid In Capital Conversion Of Warrants To Equity Classification AdjustmentsToAdditionalPaidInCapitalConversionOfWarrantsToEquityClassification	1110000
CY2015	kmph	Common Stock Issued During Period From Warrants Exercised CommonStockIssuedDuringPeriodFromWarrantsExercised	270038
CY2017	kmph	Common Stock Issued During Period From Warrants Exercised CommonStockIssuedDuringPeriodFromWarrantsExercised	698
CY2016	kmph	Common Stock Issued During Period From Warrants Exercised CommonStockIssuedDuringPeriodFromWarrantsExercised	141095
CY2015	kmph	Operating And Capital Leases Rent Expense Net OperatingAndCapitalLeasesRentExpenseNet	300000
CY2017	kmph	Operating Loss Carryforward Expiration Year OperatingLossCarryforwardExpirationYear
CY2017Q4	kmph	Other Prepaid Expenses And Current Assets OtherPrepaidExpensesAndCurrentAssets	1384000
CY2016Q4	kmph	Other Prepaid Expenses And Current Assets OtherPrepaidExpensesAndCurrentAssets	98000
CY2017Q4	kmph	Number Of Manufacturing Arrangements NumberOfManufacturingArrangements	1
CY2017	kmph	Operating And Capital Leases Rent Expense Net OperatingAndCapitalLeasesRentExpenseNet	600000
CY2016	kmph	Operating And Capital Leases Rent Expense Net OperatingAndCapitalLeasesRentExpenseNet	600000

Files In Submission

Name	View Source	Status
0001437749-18-005932-index-headers.html	Edgar Link	pending
0001437749-18-005932-index.html	Edgar Link	pending
0001437749-18-005932.txt	Edgar Link	pending
0001437749-18-005932-xbrl.zip	Edgar Link	pending
ex_104675.htm	Edgar Link	pending
ex_104676.htm	Edgar Link	pending
ex_104678.htm	Edgar Link	pending
ex_104679.htm	Edgar Link	pending
ex_104680.htm	Edgar Link	pending
ex_106556.htm	Edgar Link	pending
ex_108319.htm	Edgar Link	pending
ex_108732.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kmph-20171231.xml	Edgar Link	completed
kmph-20171231.xsd	Edgar Link	pending
kmph-20171231_cal.xml	Edgar Link	unprocessable
kmph-20171231_def.xml	Edgar Link	unprocessable
kmph-20171231_lab.xml	Edgar Link	unprocessable
kmph-20171231_pre.xml	Edgar Link	unprocessable
kmph20171231_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

2017 Q4 Form 10-K Financial Statement

#000143774918005932 Filed on March 30, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA ZEVRA THERAPEUTICS, INC. Stock $zvra

2017 Q4 Form 10-K Financial Statement

#000143774918005932 Filed on March 30, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra